Progress in polymeric nano-medicines for theranostic cancer treatment

93Citations
Citations of this article
114Readers
Mendeley users who have this article in their library.

Abstract

Cancer is a life-threatening disease killing millions of people globally. Among various medical treatments, nano-medicines are gaining importance continuously. Many nanocarriers have been developed for treatment, but polymerically-based ones are acquiring importance due to their targeting capabilities, biodegradability, biocompatibility, capacity for drug loading and long blood circulation time. The present article describes progress in polymeric nano-medicines for theranostic cancer treatment, which includes cancer diagnosis and treatment in a single dosage form. The article covers the applications of natural and synthetic polymers in cancer diagnosis and treatment. Efforts were also made to discuss the merits and demerits of such polymers; the status of approved nano-medicines; and future perspectives.

Cite

CITATION STYLE

APA

Ali, I., Alsehli, M., Scotti, L., Scotti, M. T., Tsai, S. T., Yu, R. S., … Chen, J. C. (2020, March 1). Progress in polymeric nano-medicines for theranostic cancer treatment. Polymers. MDPI AG. https://doi.org/10.3390/polym12030598

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free